Cargando…

Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer

Thyroid cancer is the most common malignancy of the endocrine system, encompassing different entities with distinct histological features and clinical behavior. The diagnostic definition, therapeutic approach, and follow-up of thyroid cancers display some controversial aspects that represent unmet m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romano, Chiara, Martorana, Federica, Pennisi, Maria Stella, Stella, Stefania, Massimino, Michele, Tirrò, Elena, Vitale, Silvia Rita, Di Gregorio, Sandra, Puma, Adriana, Tomarchio, Cristina, Manzella, Livia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303548/ https://www.ncbi.nlm.nih.gov/pubmed/34299334 http://dx.doi.org/10.3390/ijms22147707

Ejemplares similares

Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
por: Tirrò, Elena, et al.
Publicado: (2021)

A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic
por: Stella, Stefania, et al.
Publicado: (2021)

Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
por: Manzella, Livia, et al.
Publicado: (2019)

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice
por: Tirrò, Elena, et al.
Publicado: (2019)

Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
por: Stella, Stefania, et al.
Publicado: (2021)

New Insights in Thyroid Cancer and p53 Family Proteins
por: Manzella, Livia, et al.
Publicado: (2017)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)

Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients
por: Stella, Stefania, et al.
Publicado: (2022)

Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer
por: Massimino, Michele, et al.
Publicado: (2023)

High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability
por: Massimino, Michele, et al.
Publicado: (2023)

The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
por: Vigneri, Paolo Giovanni, et al.
Publicado: (2015)

Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
por: Massimino, Michele, et al.
Publicado: (2018)

Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far
por: Stella, Stefania, et al.
Publicado: (2023)

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023)

The other side of the coin: dissecting molecular mechanisms behind hereditary breast cancer in search of therapeutic opportunities
por: Stella, Stefania, et al.
Publicado: (2021)

BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
por: Pennisi, Maria Stella, et al.
Publicado: (2019)

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
por: Tirrò, Elena, et al.
Publicado: (2019)

Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells
por: Massimino, Michele, et al.
Publicado: (2021)

Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily
por: Stella, Stefania, et al.
Publicado: (2022)

Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports
por: Pennisi, Maria Stella, et al.
Publicado: (2023)

AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
por: Martorana, Federica, et al.
Publicado: (2021)

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib
por: Stella, Stefania, et al.
Publicado: (2019)

IRF5 promotes the proliferation of human thyroid cancer cells
por: Massimino, Michele, et al.
Publicado: (2012)

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019)

Liquid biopsies in pediatric oncology: opportunities and obstacles
por: Sundby, R. Taylor, et al.
Publicado: (2022)

A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
por: Tirrò, Elena, et al.
Publicado: (2022)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology
por: Werner, Bonnita, et al.
Publicado: (2022)

Exosome-based liquid biopsies in cancer: opportunities and challenges
por: Yu, W., et al.
Publicado: (2021)

Liquid Biopsy in Thyroid Cancer: New Insight
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls
por: Cafforio, Paola, et al.
Publicado: (2021)

Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology
por: Muinelo-Romay, Laura, et al.
Publicado: (2018)

Lipid Biomarkers in Liquid Biopsies: Novel Opportunities for Cancer Diagnosis
por: Sagini, Krizia, et al.
Publicado: (2023)

Application of Liquid-Based Cytology to Fine-Needle Aspiration Biopsies of the Thyroid Gland
por: Rossi, Esther Diana, et al.
Publicado: (2012)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)

Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy
por: Farncombe, Kirsten M., et al.
Publicado: (2023)

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring
por: Batool, Syeda Maheen, et al.
Publicado: (2023)

Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays
por: Ono, Shigeshi, et al.
Publicado: (2015)

Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities
por: Soelter, Tabea M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_otru9igcvteh7pg7vuq0tts26t